关注
Nazir Ismail
Nazir Ismail
National Institute of Communicable Diseases
在 nicd.ac.za 的电子邮件经过验证
标题
引用次数
引用次数
年份
World Health Statistics 2016 [OP]: Monitoring Health for the Sustainable Development Goals (SDGs)
World Health Organization
World Health Organization, 2016
22184*2016
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ...
The Lancet infectious diseases 15 (10), 1193-1202, 2015
6292015
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis
P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ...
Nature communications 6 (1), 10063, 2015
6072015
Transmission of extensively drug-resistant tuberculosis in South Africa
NS Shah, SC Auld, JCM Brust, B Mathema, N Ismail, P Moodley, ...
New England Journal of Medicine 376 (3), 243-253, 2017
3432017
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
3342018
Identifying lineage effects when controlling for population structure improves power in bacterial association studies
SG Earle, CH Wu, J Charlesworth, N Stoesser, NC Gordon, TM Walker, ...
Nature microbiology 1 (5), 1-8, 2016
2822016
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
K Schnippel, N Ndjeka, G Maartens, G Meintjes, I Master, N Ismail, ...
The lancet respiratory medicine 6 (9), 699-706, 2018
2712018
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ...
The Lancet infectious diseases 16 (10), 1185-1192, 2016
2092016
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ...
The Lancet Infectious Diseases 18 (6), 675-683, 2018
1582018
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations
TC Rodwell, F Valafar, J Douglas, L Qian, RS Garfein, A Chawla, J Torres, ...
Journal of clinical microbiology 52 (3), 781-789, 2014
1572014
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ...
The Lancet Microbe 3 (4), e265-e273, 2022
1542022
Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe
M Hunt, P Bradley, SG Lapierre, S Heys, M Thomsit, MB Hall, KM Malone, ...
Wellcome open research 4, 2019
1272019
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
N Ndjeka, K Schnippel, I Master, G Meintjes, G Maartens, R Romero, ...
European Respiratory Journal 52 (6), 2018
1212018
Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains
LT Daum, JD Rodriguez, SA Worthy, NA Ismail, SV Omar, AW Dreyer, ...
Journal of clinical microbiology 50 (12), 3831-3837, 2012
1152012
Modernizing Medical Microbiology (MMM) Informatics Group. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a …
TM Walker, TA Kohl, SV Omar, J Hedge, C Del Ojo Elias, P Bradley, ...
Lancet Infect Dis 15 (10), 1193-1202, 2015
1102015
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data
AS Dean, M Zignol, AM Cabibbe, D Falzon, P Glaziou, DM Cirillo, ...
PLoS medicine 17 (1), e1003008, 2020
1092020
Defining bedaquiline susceptibility, resistance, cross-resistance and associated genetic determinants: a retrospective cohort study
NA Ismail, SV Omar, L Joseph, N Govender, L Blows, F Ismail, H Koornhof, ...
EBioMedicine 28, 136-142, 2018
1082018
Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis
A Nanoo, A Izu, NA Ismail, C Ihekweazu, I Abubakar, D Mametja, ...
The Lancet infectious diseases 15 (9), 1066-1076, 2015
992015
Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey
NA Ismail, L Mvusi, A Nanoo, A Dreyer, SV Omar, S Babatunde, ...
The Lancet Infectious Diseases 18 (7), 779-787, 2018
982018
A multilaboratory, multicountry study to determine MIC quality control ranges for phenotypic drug susceptibility testing of selected first-line antituberculosis drugs, second …
K Kaniga, DM Cirillo, S Hoffner, NA Ismail, D Kaur, N Lounis, B Metchock, ...
Journal of Clinical Microbiology 54 (12), 2963-2968, 2016
93*2016
系统目前无法执行此操作,请稍后再试。
文章 1–20